Israeli venture capital fund Welltech Ventures, which specializes in wellness technologies, has invested $1 million in X-trodes, a startup in the field of bio-convergence. The company, which has already raised $2 million to date, has developed an innovative technology to monitor and analyze physiological and neurological signals for patients at home.
“X-trodes’ solution is very exciting, and it will bring about a real revolution in the realm of healthcare and wellness,” explain Galit Horovitz and Amir Alroy, co-founders of Welltech Ventures. “The ability and the need to follow patients remotely, which will give them greater control over their bodies and their daily routines, has become a central issue that is even more sharply felt in the coronavirus era.”